The Wall Street Journal: Omicron variant unlikely to cause severe illness in vaccinated people, BioNTech founder saysMarket Watch • 11/30/21
FDA May Authorize Pfizer-BioNTech COVID-19 Booster Shots For Age 16-17 Next Week: WSJBenzinga • 11/30/21
BioNTech has already started developing a new Omicron version of its COVID-19 vaccineBusiness Insider • 11/29/21
Pfizer-BioNTech investigating new Covid variant, while J&J say they are testing their vaccine against itCNBC • 11/26/21
Forget reopening. The new COVID variant has 'stay-at-home' stocks rebounding.Business Insider • 11/26/21
Pandemic-related stocks from Zoom to Moderna jump as new coronavirus variant raises alarms and triggers lockdownsBusiness Insider • 11/26/21
BioNTech says it will know in 2 weeks whether the COVID-19 vaccine it developed with Pfizer works against the new variant rapidly spreading in southern AfricaBusiness Insider • 11/26/21
Pfizer and BioNTech Receive Positive CHMP Opinion for COMIRNATY® in Children 5 to under 12 Years of Age in the European UnionGlobeNewsWire • 11/25/21
Pfizer-BioNTech's COVID-19 Vaccine Shows 100% Effectiveness In Long Term Analysis In AdolescentsBenzinga • 11/22/21
Pfizer's Covid-19 Shot Offers 100% Long-Term Protection For Young Teens, Trial ShowsForbes • 11/22/21
Pfizer and BioNTech say late-stage trial shows vaccine effective for 12- to 15-year-oldsMarket Watch • 11/22/21